NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 99,605,545
Number of holders: 359
Total 13F shares, excl. options: 90,478,199
Shares change: +1,731,607
Total reported value, excl. options: $7,833,712,957
Value change: +$134,190,014
Put/Call ratio: 82.02%
Number of buys: 178
Number of sells: -200
Price: $86.55

Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2020

455 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q1 2020.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 359 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 90,478,199 shares of 99,605,545 outstanding shares and own 90.84% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8,503,688 shares), JANUS HENDERSON GROUP PLC (7,629,199 shares), FMR LLC (7,283,421 shares), BlackRock Inc. (6,955,404 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,570,771 shares), Capital International Investors (6,020,103 shares), Bellevue Group AG (3,259,474 shares), PERCEPTIVE ADVISORS LLC (3,063,263 shares), STATE STREET CORP (2,511,261 shares), and FRANKLIN RESOURCES INC (1,677,681 shares).
This table shows the top 359 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.